Helsinn Group Announces Upcoming Presentation of Phase III data in NEPA (netupitant/palonestron) at MASCC/ISOO Congress in Washington DC
Helsinn, a Swiss pharmaceutical group focused on building quality cancer care products, today announces that data showin…